RELMADA THERAPEUTICS, INC.·4

Nov 6, 7:30 AM ET

Shenouda Maged 4

4 · RELMADA THERAPEUTICS, INC. · Filed Nov 6, 2025

Insider Transaction Report

Form 4
Period: 2025-11-05
Shenouda Maged
Chief Financial Officer
Transactions
  • Purchase

    Common Stock

    2025-11-05$2.20/sh+500,000$1,100,000788,335 total

Documents

1 file
  • 4
    ownership.xmlPrimary